Skip to content
Columbia University
Motor Neuron Center
Home
About Us
Research
News
Events
Support the Center
Augmenting the SMN Protein to Treat Infantile Spinal Muscular Atrophy
SMN repletion is effected either by using an antisense moiety such as Nusinersen or by transducing cells with an AAV9 vector harboring a copy of the SMN1 gene. Each approach raises SMN in the cell and rescues/prevents the SMA phenotype.